Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Wouters, I; Desmet, S; Van Heirstraeten, L; Herzog, SA; Beutels, P; Verhaegen, J; Goossens, H; Van Damme, P; Malhotra-Kumar, S; Theeten, H; NPcarriage Study Group.
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.
Euro Surveill. 2020; 25(5):
Doi: 10.2807/1560-7917.ES.2020.25.5.1900303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Herzog Sereina Annik
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BackgroundThe current carriage study was set up to reinforce surveillance during/after the PCV13-to-PCVC10 switch in Belgium.AimThis observational study monitored carriage of Streptococcus pneumoniae (Sp) serotypes, particularly those no longer covered (3, 6A, 19A), as well as Haemophilus influenzae (Hi), because PCV10 contains the non-typeable Hi protein D.MethodsA total of 2,615 nasopharyngeal swabs from children (6-30 months old) attending day care were collected in three periods over 2016-2018. Children's demographic and clinical characteristics and vaccination status were obtained through a questionnaire. Sp and Hi were identified by culture and PCR. Pneumococcal strains were tested for antimicrobial (non-)susceptibility by disc diffusion and serotyped by Quellung-reaction (Quellung-reaction and PCR for serotypes 3, 6A, 19A).ResultsThe carriage prevalence of Sp (> 75%) remained stable over the successive periods but that of Hi increased (87.4%, 664 Hi-carriers/760 in 2016 vs 93.9%, 895/953 in 2017-2018). The proportion of non-PCV13 vaccine serotypes decreased (94.6%, 438 isolates/463 in 2016 vs 89.7%, 599/668 in 2017-2018) while that of PCV13-non-PCV10 vaccine serotypes (3 + 6A + 19A) increased (0.9%, 4 isolates/463 in 2016 vs 7.8%, 52/668 in 2017-2018), with serotype 19A most frequently identified (87.9%, 58/66 isolates). Non-susceptibility of pneumococci against any of the tested antibiotics was stable over the study period (> 44%).ConclusionsDuring and after the PCV13-to-PCV10 vaccine switch, the proportion of non-PCV13 serotypes decreased, mainly due to a serotype 19A carriage prevalence increase. These results complement invasive pneumococcal disease surveillance data, providing further basis for pneumococcal vaccination programme policy making.
- Find related publications in this database (using NLM MeSH Indexing)
- Anti-Bacterial Agents - pharmacology
- Anti-Bacterial Agents - epidemiology
- Carrier State - epidemiology
- Carrier State - immunology
- Carrier State - microbiology
- Child, Preschool -
- Drug Resistance, Bacterial -
- Female -
- Haemophilus influenzae - drug effects
- Haemophilus influenzae - immunology
- Haemophilus influenzae - isolation & purification
- Humans -
- Immunization Programs - statistics & numerical data
- Infant -
- Male -
- Microbial Sensitivity Tests -
- Nasopharynx - microbiology
- Pneumococcal Infections - epidemiology
- Pneumococcal Infections - immunology
- Pneumococcal Infections - microbiology
- Pneumococcal Infections - prevention & control
- Pneumococcal Vaccines - administration & dosage
- Prevalence -
- Serogroup -
- Streptococcus pneumoniae - drug effects
- Streptococcus pneumoniae - immunology
- Streptococcus pneumoniae - isolation & purification
- Vaccination -